Medical Quality Assurance Expert Witnesses: 8

Lori S. Corley MD, FAAP, is Board Certified in Pediatric and Adolescent Medicine. Also certified in Basic Life Support (BLS) and Neonatal Resuscitation Program (NRP), she provides comprehensive medical care for infants, children, and adolescents, acting as their primary care physician. 

Employment Experience

• Consultant / Expert Witness for Medical Malpractice cases - Case list available on request (2004-present)
• Clinical Assistant Professor of Pediatrics, Georgia Health Sciences University /Medical College of Georgia (2002-present)
• Adjunct Professor, MSN Primary Care Nurse Practitioner Program, Kennesaw State University (2001-present)

Dr. Corley provides litigation support services to attorneys representing Plaintiff and Defense. She is available to review medical records, give depositions, and trial testimony for cases that include issues of causation, quality control, and standard of care. 

Areas of Expertise:

• Pediatric Medicine - General infections and illnesses (fevers, sore throats, ear infections, etc.) and minor injuries, as well as some diseases (septic shock), emotional stressors in children that may lead to psychiatric or mental health complications, including developmental and anxiety disorders, behavioral problems and functional complications
• Adolescent Medicine - Sexually transmitted diseases (STDs), substance abuse, obesity, eating disorders, mental illnesses (ADHD), acne, pregnancy, birth control programs, menstrual disorders, problems with puberty, among many other conditions and disorders

EXPERTISE IN: 1. The pathobiology, clinico-pathologic correlation, and histopathologic diagnosis of: diseases of the esophagus, stomach, small intestine, colon, rectum, anus, liver, and pancreas. 2. Human neoplasms (cancer) and preneoplastic conditions. 3. Establishing standard of care, causation and cause of death. 

BACKGROUND: 

1. Anatomic Pathology Residency: Washington Univ-Barnes Hospital 1991-94.
2. Oncologic Pathology Fellowship: M.D. Anderson Cancer Center 1994-95.
3. Gastrointestinal and Liver Pathology Fellowship: Harvard-Brigham & Women's Hospital 1995-96.
4. Instructor at Harvard Medical School: 1996-1998.
5. Assistant Professor and Director of Gastrointestinal Pathology Division at UT-Health Science Center-Hermann Hospital, Houston Medical Center: 08/1998 - 12/2000.
6. Staff GI Pathologist and Quality Assurance Director at Caris/Miraca Life Sciences, Dallas TX: 01/2001 - 04/2012.  Dr. Torres was instrumental in creating a unique model of Gastrointestinal Pathology subspecialty-focused laboratory, during his tenure at Caris/Miraca Life Sciences.
7. Staff Pathologist, Anatomic Pathology Division of the North Shore-LIJ Health System, Long Island NY: 05/2012 - 05/2015.
8. Staff Pathologist, Anatomic Pathology Division of Alliance Health Sciences, Dallas TX: 06/2015 - 05/2020.
9. Sole Proprietor of Expert Pathology Consultation Services Laboratory since 01/2020, which provides diagnostic pathology services to hundreds of clinicians of different subspecialties.         

Spine Surgery and Spine Medicine Consultant

The concepts of evidence-based medicine have been the cornerstone of Dr. Dillin’s education during his spine surgery fellowship in Neurosurgery and Orthopaedic Surgery and the format for decision-making in his subsequent practice. The critical analytic features inherent in the ‘best evidence’ approach to patients have permeated his writing and his lectures, allowing flexible adaptation as the science has changed. Since July 1985, Dr. Dillin has been exclusively devoted to clinical spine, interventional spine, and spine surgery practice. The combination of clinical critical thinking in conjunction with evidence-based medicine practice, allows spine specialty focus on any Independent Medical Evaluations or Medical-Legal Reviews. He is in clinical practice performing spine surgery, spine interventions, and evaluating patients with spine conditions. He is licensed in California, Texas, Arizona, Florida and Nevada. Dr. Dillin was a former partner at the Kerlan-Jobe Orthopaedic Clinic. I spent 2022-2023 in clinical practice and at the Effective Writing in Health Care program sponsored by Harvard Medical School. The program encompassed online and onsite (Boston) attendance. My study subject was the history of the expert witness in general, and more specifically, the medical expert witness. My capstone project, from the ‘Writing for the Public’, division is attached. This is the narrative account of “The Trial of the Medical Expert Witness.”

Litigation Support - For over 35 years, Dr. Dillin has traveled to refine and acquire the technical skills invested in Spine Surgery and Spine Interventions. His expert witness activity is embodied in his Harvard Capstone, "The Trial of the Medical Expert Witness." Dr. Dillin offers Independent Medical Evaluations and/or Medical-Legal Review, thorough reporting, depositions, and trial testimony as needed.

Areas of Expertise:

Rouzbeh R. Taghizadeh, PhD, is a Regenerative Medicine and Biomedical Engineering Expert offering more than 20 years of expertise as a Scientist, Innovator, and Entrepreneur in the development, processing, manufacturing of tissues, including bone marrow, umbilical cord (blood & tissue), amnion, chorion, placenta, adipose (fat), and other organs for clinical and non-clinical use, while considering the complex regulatory, trade secret, patent claims that arises from these areas.

Litigation Support - Dr. Taghizadeh provides subject matter expertise and expert witness testimony for scientific, technical, regulatory, trade secret and patent claims in the areas of:

Dr. Taghizadeh specializes in adult stem cells, primarily human hematopoietic and mesenchymal stem cells, the regenerative cells involved in successful bone marrow and umbilical cord blood transplantations, uniquely positions him to approach science and business with the same keen powers of insight that have consistently reaped success surmounting scientific and medical barriers in the field. 

He earned his Ph.D. in Stem Cell Bioengineering in 2006 from the Massachusetts Institute of Technology (MIT) and co-founded AuxoCell Laboratories, Inc. as Chief Scientific Officer in 2008 after completing his post-doctoral training from MIT and the Boston Biomedical Research Institute.

View Dr. Rouzbeh R. Taghizadeh's Consulting Profile.

Victor L. Mandoff, BSc, MBBS, is a Board-Certified fully practicing Professor of Anesthesiology at a teaching hospital. With 17 years of experience in Anesthesiology and 10 years in Critical Care Medicine, his training keeps him current in the knowledge and practice of Evidence Based Medicine (EBM). Evidence Based Medicine is the integration of individual clinical expertise with the best available research evidence from systematic research and the patient's values and expectations.

UAMS Medical Center provides care to the highest acuity patients from the state and surrounding areas. It is the only level-one trauma center in Arkansas and the only one that does liver transplantations. Dr. Mandoff provides anesthesia for a variety of cases like liver transplants, kidney transplants, vascular surgery, thoracic, obstetric, neurosurgical, ENT, outpatient, GI, radiology, Cath Lab, Electroconvulsive therapy, etc. 

Litigation Support - Dr. Mandoff offers expert witness services to attorneys for plaintiff and defendant. Services include medical record review, thorough reporting, depositions, and trial testimony.

Areas of Expertise:

Dr. Mandoff is the director of MOCA Simulation for Anesthesiologists, the Assistant Medical Director of the Simulation Center, and the Director of Liver Transplant Team and Transplant Anesthesia at the University of Arkansas for Medical Science. He is an award-winning educator who feels privileged to teach medical students, nurses, residents, SRNAs and junior faculty, and other faculty using simulation training. Dr. Mandoff has won many teaching awards, including “Golden Apple Award,” “Red Sash Award,” and  “Educational Excellence Award,” presented by residents, students, and the College of Medicine.

Dr. Mandoff is a Fellow of the American Society of Anesthesiologists (FASA). The FASA designation is the “highest acknowledgment that recognizes years of dedication to exceptional education, leadership, and commitment to the specialty” as per the American Society of Anesthesiologists website. He is also Critical Care Fellowship trained at the Cleveland Clinic Medical Foundation, Critical Care Board Certified, and practiced Critical Care Medicine from 2006 to about 2016.

An Oral Board Examiner for the American Board of Anesthesiology, Dr. Mandoff has been named in Arkansas Times Best Doctors in Arkansas list in both Anesthesiology and Critical Care Medicine.

Dr. Nicholas Ladikos is a Clinical Pharmacist and Drug Regimen Error expert. He started and operationalized system-level programs at the Johns Hopkins Hospital and the National Institutes of Health (NIH), and is also the founder of MedOp Advisors, a concierge medication, nutrition, and health & wellness advisory company.

Dr. Ladikos also serves as a Medical Director for Optum Serve and is a Professor at both Texas Tech University and Arizona College of Nursing. He co-authored numerous papers in the areas of infectious diseases and antimicrobial stewardship, pharmacoeconomics, pharmacogenomics, geriatrics, and therapies in the lung transplant population. He conducts physician training and clinical staff education regarding medication trends and utilization, identification and mitigation for potential medication fraud, waste and abuse, and collaborates in disease management and population health programs.

Litigation Support - Dr. Ladikos is a subject matter expert in several pharmacy-related areas and serves as an expert witness on a number of Pharmaceutical litigation matters. Numerous hospitals have used his skillset and expertise in medical chart reviews to identify errors in medication preparation and prescribing, drug side effect management, standard of care compliance, continuing education delivery, and personnel assessments.

Areas of Expertise:

Dr. Ladikos currently develops and leads clinical programs that help stakeholders use and advance medication management tools (e.g., formularies, pharmacy, therapeutics committees and medication therapy management), quality metrics, research methodologies, and health information technology. He has experience in medication utilization statistical analyses to demonstrate adherence to evidence-based practice guidelines and inform health program policies.

Dr. Ladikos examines pharmacoeconomic trends to ensure that a cost-effective pharmacy benefit is administered to members, and consults with care management team to provide guidance regarding member goals. 

Timothy A. Anderson, MS, MBA, is a former FDA Review Chemist with over 43 years of career experience in Pharmaceutical R&D, Quality Operations, and Regulatory Affairs. A uniquely interdisciplined individual, he melds comprehensive pharmaceutical industrial R&D, business development, QA/QC, and consultancy experiences with formal FDA-tenured regulatory credentials.

As a consultant in his own pharmaceutical development advisory firm for over 29 years, Mr. Anderson has furnished clients with services ranging from providing regulatory application filing strategies specialized in Chemistry and Manufacturing Controls (CMC), to current Good Manufacturing Practice (cGMP), quality system regulation (QSR) audits for finished dosage, and active pharmaceutical ingredient (API) manufacturing, as well as for device, drug-device combination, and biologic products.  Technical and regulatory compliance due diligence services are furnished to institutional investors.  

Mr. Anderson has contributed to regulatory approvals for over 50 drug and drug / device applications, spanning generic (ANDA) and innovator NDA, BLA, 510(k), PMA, and 505(b)(2) applications, and has provided regulatory compliance remediation services to resolve Form 483, Warning Letter, and Consent Decree issues.    

Litigation Support - Mr. Anderson has been deposed, testified in Federal Court, and functioned as a Subject Matter Expert Witness  and consultant to litigation in over 20 cases in the Pharmaceutical, Biologic, and Device Life Sciences space, focused in areas of Antitrust, Patent, and Product Liability.

View Timothy Anderson's Business Consulting Profile.

Dr. Jeffrey Stone, DO, MPH, FCCWS, specializing in Wound Care and Hyperbaric Medicine, served as Medical and Fellowship Director for the Hyperbaric Medicine Unit at the Institute for Exercise & Environmental Medicine at Texas Health Dallas from 1992- May 2016. Dr. Stone received his medical degree from Western States University and received a Master of Public Health degree from Harvard University. Dr. Stone completed a residency in aerospace medicine at Brooks Air Force Base and a fellowship in hyperbaric medicine and Wound care at the U.S. Air Force School of Aerospace Medicine. Dr. Stone started visiting nursing facilities in the Dallas Metroplex  in the early 1990's teaching, educating and caring for individuals with chronic wounds. He is one of the first 60 physicians in the U.S. to receive his certification in Wound Care. Dr. Stone currently provides care to patients in acute care, LTAC, long term care facilities SNF and Nursing Home) and outpatient care.

Dr. Stone has been widely published in many medical journals regarding his expertise in Wound Care and Hyperbaric Medicine. He serves as an Expert Witness for Peer Reviews, Legal Reviews, and Medical Malpractice Cases.

Areas of Expertise: Wound Care and Hyperbaric Oxygen-

• Pressure Sores
• Arterial Ulcers
• Diabetic Foot Wounds
• Acute Traumatic Ischemias
• Decubitus Ulcers
• Non-Healing Wounds, Venous or Arterial or Pressure Related

View Consulting Profile.